Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Periodontal Health and Treatment Outcomes in Students From Three Countries

16. november 2026 oppdatert av: Esra İlkerli Şençağlı

Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries

This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.

A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.

The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.

Studieoversikt

Status

Rekruttering

Detaljert beskrivelse

This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.

A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.

At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.

All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.

Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.

The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.

The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.

Studietype

Intervensjonell

Registrering (Antatt)

348

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

      • Mórfou, Kypros
        • Rekruttering
        • Cyprus Health and Social Sciences University
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Being 18 years of age or older.
  • Having been born and raised in a country different from the country of current study.
  • Currently being enrolled as a student at Cyprus Health and Social Sciences University.
  • Having received no periodontal treatment within the previous six months.
  • Having at least 20 natural teeth.
  • Voluntarily agreeing to participate in the study and providing written informed consent.

Exclusion Criteria:

  • Completely edentulous individuals.
  • Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
  • Individuals with a history of periodontal surgery.
  • Pregnant or breastfeeding individuals.
  • Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Periodontal Treatment Group

All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes.

Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Probing Pocket Depth (PPD)
Tidsramme: Baseline and 3 weeks after periodontal treatment

Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups.

Baseline and 3 weeks after periodontal treatment

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Tidsramme: Baseline and 3 weeks

Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3:

0: No plaque.

  1. A film of plaque adhering to the free gingival margin and adjacent tooth area, detectable only by running a probe across the tooth surface.
  2. Moderate accumulation of soft deposits within the gingival pocket or on the tooth and gingival margin, visible to the naked eye.
  3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Tidsramme: Baseline and 3 weeks

Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3:

0: Normal gingiva, no inflammation.

  1. Mild inflammation, slight color change and slight edema, with no bleeding on probing.
  2. Moderate inflammation, redness, edema, and glazing, with bleeding on probing.
  3. Severe inflammation, marked redness and edema, ulceration, and a tendency to spontaneous bleeding.

The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Clinical Attachment Level (CAL)
Tidsramme: Baseline and 3 weeks
Baseline and 3 weeks
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Tidsramme: Baseline and 3 weeks

Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows:

Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility.

Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Bleeding on Probing (BOP) Percentage
Tidsramme: Baseline and 3 weeks

Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing.

Each periodontal site will be recorded using a dichotomous scoring system:

Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing.

The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100.

BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100.

The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation.

Baseline and 3 weeks
Prevalence and Severity of Periodontal Disease
Tidsramme: Baseline
Baseline

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
  • Hovedetterforsker: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

6. mai 2026

Primær fullføring (Antatt)

6. mai 2029

Studiet fullført (Antatt)

6. mai 2029

Datoer for studieregistrering

Først innsendt

6. november 2026

Først innsendt som oppfylte QC-kriteriene

16. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

16. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere